Jubilant Ingrevia has entered into a binding agreement with Zettaone Technologies India for the acquisition of a 40% strategic stake for Rs 189.2 crore. Following completion of the proposed acquisition, Zettaone Technologies will become an associate company of Jubilant Ingrevia. The acquisition is proposed to be completed in two tranches, with the first tranche expected to close by November 2026 and the second tranche is expected to close by September 2027.
This acquisition will allow the company to capitalize on its proven manufacturing and customer-centric capabilities in CDMO space, while further strengthening its engagement with customers across the electronics and semiconductor value chain.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
